Cardiol Therapeutics Announces Completion of the MAvERIC Phase II Study in Recurrent Pericarditis with Results to be Presented at the American Heart Association Scientific Sessions 2024
Full clinical data will be reported in an oral presentation at the…
Aduro Enters Another Multi-Billion Dollar Market
For Aduro Clean Technologies, Inc. (CSE: ACT) (OTCQB: ACTHD) (FSE: 9D5), recycling…
Aduro Clean Technologies files new patent application to transform waste plastics and renewable oils into high value BTX chemicals